Track Statera BioPharma's minority interest ($73K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2022), STAB shows a minority interest of $73K. That compares with $72K in the prior-year period — up 1.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, STAB's minority interest is now $73K (was $72K) — a 1.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Statera BioPharma is outperforming or lagging.
Tracking STAB's minority interest over time shows whether Statera BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $73K That compares with $72K in the prior-year period — up 1.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this minority interest page, Stockcircle has Statera BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $73K) with ownership activity and broader fundamentals.
Statera BioPharma's minority interest is $73K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.